Phospholipase D Family Member 4 Regulates Microglial Phagocytosis and Remyelination via the AKT Pathway in a Cuprizone‐Induced Multiple Sclerosis Mouse Model

Ran Sun,Tengyun Ma,Zheng Zhao,Yan Gao,Juan Feng,Xue Yang

DOI: https://doi.org/10.1111/cns.70111

2024-11-23

CNS Neuroscience & Therapeutics

Abstract:PLD4 is upregulated in CPZ‐induced MS and modulates microglial phagocytosis and remyelination via the AKT pathway. PLD4 deficiency resulted in inhibition of microglial phagocytosis of myelin debris and impaired remyelination in the corpus callosum. Aims Remyelination is an endogenous repair process that is often deficient in multiple sclerosis (MS). Stimulation of remyelination is thought to help limit the progression of MS. This study aimed to investigate the expression pattern and function of a microglial phagocytosis‐related gene, phospholipase D family member 4 (PLD4), in a cuprizone (CPZ)‐induced MS mouse model. Methods The extent of remyelination was assessed using LFB staining. Myelin phagocytosis assay was used to investigate the effect of Pld4 on microglial phagocytic activity. Results Pld4 was upregulated in the corpus callosum during demyelination and remyelination. AAV9‐mediated Pld4 deficiency impaired remyelination and reduced the number of Olig2‐positive cells. In the corpus callosum of Pld4‐deficient mice, the microglial phagocytosis marker MAC2 was reduced, accompanied by inhibition of TrkA/AKT signaling. Similarly, the phagocytosis assay showed that Pld4 knockdown significantly inhibited myelin debris phagocytosis by BV2 cells. The AKT activator SC79 reversed the Pld4 deficiency‐induced inhibition of microglial phagocytic activity and rescued the impaired remyelination in Pld4‐deficient mice. Conclusion PLD4 is upregulated in CPZ‐induced MS and modulates microglial phagocytosis and remyelination via the AKT pathway. Our findings provide experimental evidence for a better understanding of the molecular mechanism of MS.

pharmacology & pharmacy,neurosciences